SE9900274D0 - New compound - Google Patents

New compound

Info

Publication number
SE9900274D0
SE9900274D0 SE9900274A SE9900274A SE9900274D0 SE 9900274 D0 SE9900274 D0 SE 9900274D0 SE 9900274 A SE9900274 A SE 9900274A SE 9900274 A SE9900274 A SE 9900274A SE 9900274 D0 SE9900274 D0 SE 9900274D0
Authority
SE
Sweden
Prior art keywords
methoxy
relates
new compound
sulfinyl
benzimidazole
Prior art date
Application number
SE9900274A
Other languages
English (en)
Swedish (sv)
Inventor
Maths Nilsson
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9900274A priority Critical patent/SE9900274D0/xx
Publication of SE9900274D0 publication Critical patent/SE9900274D0/xx
Priority to DZ000003A priority patent/DZ3001A1/xx
Priority to TW089100451A priority patent/TWI269795B/zh
Priority to HU0105313A priority patent/HU226766B1/hu
Priority to US09/530,248 priority patent/US6511996B1/en
Priority to AT00903058T priority patent/ATE236899T1/de
Priority to ES00903058T priority patent/ES2193937T3/es
Priority to DK00903058T priority patent/DK1149090T3/da
Priority to YU53801A priority patent/RS50200B/sr
Priority to NZ512804A priority patent/NZ512804A/en
Priority to EEP200100395A priority patent/EE04240B1/xx
Priority to DE60002042T priority patent/DE60002042T2/de
Priority to AU24694/00A priority patent/AU768676B2/en
Priority to UA2001074906A priority patent/UA71594C2/uk
Priority to CZ20012730A priority patent/CZ300504B6/cs
Priority to RU2001119054A priority patent/RU2237666C2/ru
Priority to PL349721A priority patent/PL197881B1/pl
Priority to SI200030105T priority patent/SI1149090T1/xx
Priority to IDW00200101639A priority patent/ID30095A/id
Priority to TR2001/02138T priority patent/TR200102138T2/xx
Priority to IL14410700A priority patent/IL144107A0/xx
Priority to PT00903058T priority patent/PT1149090E/pt
Priority to SK1037-2001A priority patent/SK285626B6/sk
Priority to CNB008032319A priority patent/CN1231477C/zh
Priority to CA002357744A priority patent/CA2357744C/en
Priority to PCT/SE2000/000087 priority patent/WO2000044744A1/en
Priority to BR0007647-3A priority patent/BR0007647A/pt
Priority to JP2000596000A priority patent/JP2002535401A/ja
Priority to EP00903058A priority patent/EP1149090B1/en
Priority to KR1020017009374A priority patent/KR100624054B1/ko
Priority to EG20000088A priority patent/EG23980A/xx
Priority to SA00200895A priority patent/SA00200895B1/ar
Priority to ARP000100330A priority patent/AR022425A1/es
Priority to MYPI20000260A priority patent/MY119095A/en
Priority to TNTNSN00017A priority patent/TNSN00017A1/fr
Priority to ZA200105526A priority patent/ZA200105526B/en
Priority to IS5989A priority patent/IS2019B/is
Priority to NO20013665A priority patent/NO319719B1/no
Priority to BG105841A priority patent/BG65060B1/bg
Priority to HK02101846.2A priority patent/HK1041259B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
SE9900274A 1999-01-28 1999-01-28 New compound SE9900274D0 (sv)

Priority Applications (40)

Application Number Priority Date Filing Date Title
SE9900274A SE9900274D0 (sv) 1999-01-28 1999-01-28 New compound
DZ000003A DZ3001A1 (fr) 1999-01-28 2000-01-09 Sel de potassium d'oméprazole-(S).
TW089100451A TWI269795B (en) 1999-01-28 2000-01-13 Potassium salt of (S)-omeprazole
KR1020017009374A KR100624054B1 (ko) 1999-01-28 2000-01-18 (ｓ)-오메프라졸의 칼륨염
IDW00200101639A ID30095A (id) 1999-01-28 2000-01-18 Garam kalium dari (s)-omeprazola
SK1037-2001A SK285626B6 (sk) 1999-01-28 2000-01-18 Forma B draselnej soli (S)-omeprazolu, spôsob jejprípravy, farmaceutický prípravok s jej obsahom ajej použitie
AT00903058T ATE236899T1 (de) 1999-01-28 2000-01-18 Neue kristallinische form des kaliumsalzes des (s)-omeprazols
ES00903058T ES2193937T3 (es) 1999-01-28 2000-01-18 Nueva forma cristalina de la sal de potasio de (s) -omeprazol.
DK00903058T DK1149090T3 (da) 1999-01-28 2000-01-18 Ny krystallinsk form af kaliumsalt af (S)-omeprazol
YU53801A RS50200B (sr) 1999-01-28 2000-01-18 Kalijumova so (s) - omeprazola
NZ512804A NZ512804A (en) 1999-01-28 2000-01-18 Potassium salt of (S)-omeprazole form B
EEP200100395A EE04240B1 (et) 1999-01-28 2000-01-18 (S)-omeprasooli kaaliumisool
DE60002042T DE60002042T2 (de) 1999-01-28 2000-01-18 Neue kristallinische form des kaliumsalzes des (s)-omeprazols
AU24694/00A AU768676B2 (en) 1999-01-28 2000-01-18 Potassium salt of (S)-omeprazole
UA2001074906A UA71594C2 (uk) 1999-01-28 2000-01-18 Калійна сіль (s)-омепразолу, спосіб її отримання, фармацевтична композиція та спосіб лікування шлунково-кишкових порушень
CZ20012730A CZ300504B6 (cs) 1999-01-28 2000-01-18 Krystalická forma draselné soli (S)-omeprazolu
RU2001119054A RU2237666C2 (ru) 1999-01-28 2000-01-18 Калиевая соль (s)-омепразола, способ ее получения и фармацевтический препарат на ее основе
PL349721A PL197881B1 (pl) 1999-01-28 2000-01-18 Postać B soli potasowej (S)-omeprazolu, sposób jej wytwarzania, środek farmaceutyczny i zastosowanie tej postaci B
SI200030105T SI1149090T1 (en) 1999-01-28 2000-01-18 Novel crystalline form of the potassium salt of (s)-omeprazole
HU0105313A HU226766B1 (en) 1999-01-28 2000-01-18 Potassium salt of (s)-omeprazole, process for its preparation and pharmaceutical composition containing the same and its use
TR2001/02138T TR200102138T2 (tr) 1999-01-28 2000-01-18 (S)-Omeprazolün potasyum tuzu.
IL14410700A IL144107A0 (en) 1999-01-28 2000-01-18 Potassium salt of (s)-omeprazole
PT00903058T PT1149090E (pt) 1999-01-28 2000-01-18 Nova forma cristalina do sal de potassio de (s)-omeprazole
US09/530,248 US6511996B1 (en) 1999-01-28 2000-01-18 Potassium salt of (s)-omeprazole
CNB008032319A CN1231477C (zh) 1999-01-28 2000-01-18 (s)－奥美拉唑钾盐
CA002357744A CA2357744C (en) 1999-01-28 2000-01-18 Potassium salt of (s)-omeprazole
PCT/SE2000/000087 WO2000044744A1 (en) 1999-01-28 2000-01-18 Potassium salt of ($i(s))-omeprazole
BR0007647-3A BR0007647A (pt) 1999-01-28 2000-01-18 Sal de potássio de forma b de (s) -omeprazol, processo para a preparação do mesmo, formulação farmacêutica, uso do sal de potássio da forma b de (s) -omeprazol, e, método de tratamento de distúrbios gastrointestinais
JP2000596000A JP2002535401A (ja) 1999-01-28 2000-01-18 （ｓ）−オメプラゾールのカリウム塩
EP00903058A EP1149090B1 (en) 1999-01-28 2000-01-18 Novel crystalline form of the potassium salt of (s)-omeprazole
EG20000088A EG23980A (en) 1999-01-28 2000-01-25 Potassium salt of (s)-omeprazole
SA00200895A SA00200895B1 (ar) 1999-01-28 2000-01-26 الملح البوتاسيومي potassium salt للأوميبرازول (s) - omeprazole
ARP000100330A AR022425A1 (es) 1999-01-28 2000-01-26 Sal potasica de omeprazol (s) forma b, procesos para su preparacion, formulaciones farmaceuticas y usos de dicha sal para la preparacion de medicamentos
MYPI20000260A MY119095A (en) 1999-01-28 2000-01-26 Potassium salt of (s)-omeprazole
TNTNSN00017A TNSN00017A1 (fr) 1999-01-28 2000-01-27 Sel de potassium d'omeprazole - (s)
ZA200105526A ZA200105526B (en) 1999-01-28 2001-07-04 Potassium salt of (S)-omeprazole.
IS5989A IS2019B (is) 1999-01-28 2001-07-05 Nýtt kristallað form kalíumsalts (S)-ómeprasóls
NO20013665A NO319719B1 (no) 1999-01-28 2001-07-26 Kaliumsalt av (S)-omeprazol
BG105841A BG65060B1 (bg) 1999-01-28 2001-08-24 Калиева сол на (s)-омепразол, метод за получаването й, фармацевтичен състав и използване
HK02101846.2A HK1041259B (zh) 1999-01-28 2002-03-11 (s)-奧美拉唑鉀鹽的新的結晶形式

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9900274A SE9900274D0 (sv) 1999-01-28 1999-01-28 New compound

Publications (1)

Publication Number Publication Date
SE9900274D0 true SE9900274D0 (sv) 1999-01-28

Family

ID=20414267

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9900274A SE9900274D0 (sv) 1999-01-28 1999-01-28 New compound

Country Status (40)

Country Link
US (1) US6511996B1 (es)
EP (1) EP1149090B1 (es)
JP (1) JP2002535401A (es)
KR (1) KR100624054B1 (es)
CN (1) CN1231477C (es)
AR (1) AR022425A1 (es)
AT (1) ATE236899T1 (es)
AU (1) AU768676B2 (es)
BG (1) BG65060B1 (es)
BR (1) BR0007647A (es)
CA (1) CA2357744C (es)
CZ (1) CZ300504B6 (es)
DE (1) DE60002042T2 (es)
DK (1) DK1149090T3 (es)
DZ (1) DZ3001A1 (es)
EE (1) EE04240B1 (es)
EG (1) EG23980A (es)
ES (1) ES2193937T3 (es)
HK (1) HK1041259B (es)
HU (1) HU226766B1 (es)
ID (1) ID30095A (es)
IL (1) IL144107A0 (es)
IS (1) IS2019B (es)
MY (1) MY119095A (es)
NO (1) NO319719B1 (es)
NZ (1) NZ512804A (es)
PL (1) PL197881B1 (es)
PT (1) PT1149090E (es)
RS (1) RS50200B (es)
RU (1) RU2237666C2 (es)
SA (1) SA00200895B1 (es)
SE (1) SE9900274D0 (es)
SI (1) SI1149090T1 (es)
SK (1) SK285626B6 (es)
TN (1) TNSN00017A1 (es)
TR (1) TR200102138T2 (es)
TW (1) TWI269795B (es)
UA (1) UA71594C2 (es)
WO (1) WO2000044744A1 (es)
ZA (1) ZA200105526B (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6875872B1 (en) * 1993-05-28 2005-04-05 Astrazeneca Compounds
SE9301830D0 (sv) * 1993-05-28 1993-05-28 Ab Astra New compounds
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US20070060556A1 (en) * 2003-05-05 2007-03-15 Yatendra Kumar Barium salt of benzimidazole derivative
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
CA2561700A1 (en) * 2004-04-16 2005-12-15 Santarus, Inc. Combination of proton pump inhibitor, buffering agent, and prokinetic agent
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
CN103772360A (zh) * 2004-06-24 2014-05-07 阿斯利康(瑞典)有限公司 制备用于制备艾美拉唑钠盐的结晶修饰物的新方法
WO2006073779A1 (en) * 2004-12-30 2006-07-13 Transform Phamaceuticals, Inc. Novel omeprazole forms and related methods
ES2259269B1 (es) 2005-03-03 2007-11-01 Esteve Quimica, S.A. Procedimiento para la preparacion de derivados de 2-(2-piridilmetilsulfinil)-bencimidazol opticamente activos.
US7576219B2 (en) 2005-10-26 2009-08-18 Hanmi Pharm. Co., Ltd Crystalline S-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing same
EP1801110A1 (en) 2005-12-22 2007-06-27 KRKA, tovarna zdravil, d.d., Novo mesto Esomeprazole arginine salt
CN100384839C (zh) * 2006-02-17 2008-04-30 中国科学院上海有机化学研究所 [(取代的吡啶基)甲基]亚磺酰基-1h-苯并咪唑类化合物及其对映体的锌盐的制备方法
US20100286208A1 (en) * 2006-06-21 2010-11-11 Bobba Venkata Siva Kumar Novel polymorph of esomeprazole potassium and process for its preparation
EP2068841B1 (en) 2006-10-05 2018-09-26 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
WO2008057802A2 (en) 2006-10-27 2008-05-15 The Curators Of The University Of Missouri Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same
US7906678B2 (en) 2006-12-04 2011-03-15 Bayer Schering Pharma Aktiengesellschaft Crystalline potassium salt of lipoxin A4 analogs
FR2920428B1 (fr) * 2007-08-29 2012-06-15 Univ Rouen Procede de dedoublement de sels de l'omeprazole
WO2009074997A2 (en) * 2007-12-10 2009-06-18 Lee Pharma Ltd. A novel process for the preparation of crystalline magnesium salt of (s)-omeprazole di hydrate
EP2143722A1 (en) 2008-07-09 2010-01-13 Lek Pharmaceuticals D.D. Process for preparation of esomeprazole sodium of high chemical purity and new forms of esomeprazole sodium
WO2010097583A1 (en) 2009-02-24 2010-09-02 Cipla Limited Esomeprazole potassium polymorph and its preparation
WO2010122583A2 (en) 2009-04-24 2010-10-28 Rubicon Research Private Limited Oral pharmaceutical compositions of acid labile substances
SI2510089T1 (sl) 2009-12-08 2015-12-31 Codexis, Inc. Sinteza prazolnih spojin
CN102319223B (zh) * 2011-09-21 2013-06-19 石药集团欧意药业有限公司 一种埃索美拉唑冻干制剂及其制备方法
CN102633776B (zh) * 2012-03-28 2014-06-18 中山市仁合药业有限公司 一种埃索美拉唑及其钠盐的制备方法
WO2024075017A1 (en) 2022-10-04 2024-04-11 Zabirnyk Arsenii Inhibition of aortic valve calcification

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
SE8301182D0 (sv) 1983-03-04 1983-03-04 Haessle Ab Novel compounds
GB2189698A (en) 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
DE4035455A1 (de) 1990-11-08 1992-05-14 Byk Gulden Lomberg Chem Fab Enantiomerentrennung
US5877192A (en) 1993-05-28 1999-03-02 Astra Aktiebolag Method for the treatment of gastric acid-related diseases and production of medication using (-) enantiomer of omeprazole
SE9301830D0 (sv) 1993-05-28 1993-05-28 Ab Astra New compounds
ATE414509T1 (de) 1994-07-08 2008-12-15 Astrazeneca Ab Aus vielen einzeleinheiten zusammengesetzte tablettierte dosisform
SE504459C2 (sv) 1994-07-15 1997-02-17 Astra Ab Förfarande för framställning av substituerade sulfoxider
GB9423970D0 (en) 1994-11-28 1995-01-11 Astra Ab Oxidation
GB9423968D0 (en) 1994-11-28 1995-01-11 Astra Ab Resolution
HRP960232A2 (en) 1995-07-03 1998-02-28 Astra Ab A process for the optical purification of compounds
SE510666C2 (sv) * 1996-12-20 1999-06-14 Astra Ab Nya Kristallmodifikationer
SE510650C2 (sv) * 1997-05-30 1999-06-14 Astra Ab Ny förening
SE510643C2 (sv) * 1997-06-27 1999-06-14 Astra Ab Termodynamiskt stabil omeprazol natrium form B

Also Published As

Publication number Publication date
UA71594C2 (uk) 2004-12-15
EG23980A (en) 2008-02-27
AU2469400A (en) 2000-08-18
YU53801A (sh) 2004-07-15
BG105841A (en) 2002-04-30
CN1339034A (zh) 2002-03-06
CA2357744A1 (en) 2000-08-03
NO20013665L (no) 2001-07-26
EE200100395A (et) 2002-10-15
DK1149090T3 (da) 2003-06-30
IS2019B (is) 2005-06-15
NZ512804A (en) 2003-07-25
CN1231477C (zh) 2005-12-14
TNSN00017A1 (fr) 2005-11-10
ATE236899T1 (de) 2003-04-15
AR022425A1 (es) 2002-09-04
EP1149090A1 (en) 2001-10-31
SK10372001A3 (sk) 2002-02-05
RU2237666C2 (ru) 2004-10-10
CZ300504B6 (cs) 2009-06-03
IS5989A (is) 2001-07-05
CA2357744C (en) 2009-06-16
EE04240B1 (et) 2004-02-16
HUP0105313A2 (hu) 2002-05-29
SI1149090T1 (en) 2003-10-31
SK285626B6 (sk) 2007-05-03
BG65060B1 (bg) 2007-01-31
CZ20012730A3 (cs) 2002-02-13
DE60002042T2 (de) 2003-12-18
NO319719B1 (no) 2005-09-05
WO2000044744A1 (en) 2000-08-03
KR100624054B1 (ko) 2006-09-18
RS50200B (sr) 2009-07-15
TWI269795B (en) 2007-01-01
JP2002535401A (ja) 2002-10-22
HK1041259A1 (en) 2002-07-05
PT1149090E (pt) 2003-07-31
HU226766B1 (en) 2009-09-28
ZA200105526B (en) 2002-10-04
KR20010101699A (ko) 2001-11-14
IL144107A0 (en) 2002-05-23
DE60002042D1 (de) 2003-05-15
US6511996B1 (en) 2003-01-28
ID30095A (id) 2001-11-01
SA00200895B1 (ar) 2006-11-11
TR200102138T2 (tr) 2001-12-21
HK1041259B (zh) 2003-10-24
DZ3001A1 (fr) 2004-03-27
AU768676B2 (en) 2003-12-18
PL197881B1 (pl) 2008-05-30
ES2193937T3 (es) 2003-11-16
MY119095A (en) 2005-03-31
HUP0105313A3 (en) 2003-01-28
BR0007647A (pt) 2001-10-16
NO20013665D0 (no) 2001-07-26
EP1149090B1 (en) 2003-04-09

Similar Documents

Publication Publication Date Title
SE9900274D0 (sv) New compound
YU60999A (sh) Novi oblik s-omeprazola
WO1999008500A3 (en) New crystalline form of omeprazole
MY127871A (en) Omeprazole sodium salt
MY125399A (en) Benzimidazole compound crystal.
UA32524C2 (uk) Спосіб одержання омепразолу
ZA989999B (en) New process for the preparation of 5-methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)sulfinyl)1H-benzimidazole
HUP0303928A2 (hu) Omeprazol kristályos formája, eljárás az előállítására és ezt tartalmazó gyógyszerkészítmények
SE0302382D0 (sv) New salts II
MXPA05009183A (es) Polimorfos de s-omeprazol.
SE0302381D0 (sv) New salts I
MY118724A (en) New crystalline form of omeprazole
YU32301A (sh) Novi kristalni oblik omeprazola
ME00197B (me) Novi postupak dobijanja trihidrata soli magnezijum-s-omeprazola